HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION
Patent Cooperation Treaty
PCT/US2020/014382
Filed on 2020-01-21
PCT/US2020/014382
Filed on 2020-01-21
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION
Taiwan
109102511
Filed on 2020-01-22
109102511
Filed on 2020-01-22
ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY
US Patent 11,192,903
Filed on 2019-12-20
Filed on 2019-12-20
Pharmaceutical Compositions Of Fenretinide Having Increased Bioavailability And Methods Of Using Them
Japan
2009-184500
Filed on 2009-08-07
2009-184500
Filed on 2009-08-07
Pharmaceutical Compositions Of Fenretinide Having Increased Bioavailability And Methods Of Using Them
Japan
2002-559023
Filed on 2001-12-05
2002-559023
Filed on 2001-12-05
COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH HPV+
MALIGNANCIES
US Patent 11,440,963
Filed on 2019-11-11
Filed on 2019-11-11
Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies
Japan
2019-561944
Filed on 2019-11-08
2019-561944
Filed on 2019-11-08
COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH
HPV+ MALIGNANCIES
European Patent
18729515.9
Filed on 2019-12-06
18729515.9
Filed on 2019-12-06
Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies
Canada
3063087
Filed on 2018-05-08
3063087
Filed on 2018-05-08